ticilimumab tremelimumab
ticilimumab tremelimumab Basic information
- Product Name:
- ticilimumab tremelimumab
- Synonyms:
-
- ticilimumab tremelimumab
- Ticilimumab
- Tremelimumab
- Research Grade Tremelimumab (DHD17203)
- Research Grade Ticilimumab (DHD17204)
- Tremelimumab (anti-CTLA-4)
- Ticilimumab|||CP-675206
- CAS:
- 745013-59-6
- MW:
- 0
- Mol File:
- Mol File
More
Less
ticilimumab tremelimumab Chemical Properties
- storage temp.
- Store at -20°C
- form
- Liquid
- color
- Colorless to light yellow
More
Less
ticilimumab tremelimumab Usage And Synthesis
Uses
Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research[1].
References
[1] Comin-Anduix B, et al. Tremelimumab: research and clinical development. Onco Targets Ther. 2016 Mar 23;9:1767-76. DOI:10.2147/OTT.S65802
ticilimumab tremelimumabSupplier
Wuhan Chemstan Biotechnology Co., Ltd. Gold
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
Wuhan Sunrise Technology Development Co., Ltd.
- Tel
- 27-027-83314682 13554138826
- whsrtech@vip.163.com
Beijing HuaMeiHuLiBiological Chemical
- Tel
- 010-56205725
- waley188@sohu.com
Shanghai EFE Biological Technology Co., Ltd.
- Tel
- 021-65675885 18964387627
- info@efebio.com
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
More
Less
ticilimumab tremelimumab(745013-59-6)Related Product Information
- Follicle stimulating hormone
- Secukinumab
- Daratumumab
- OMALIZUMAB
- Dulaglutide
- Trastuzumab emtansine
- palivizumab
- Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer
- Eculizumab
- Ranibizumab
- CETUXIMAB
- Adalimumab
- Trastuzumab
- Rituximab
- Bevacizumab
- Nivolumab
- Lipopolysaccharides
- belimumab